参考文献/References:
[1] Segura-Bruna N, Rodriguez-Campello A, Puente V, et al.
Valproate-induced hyperammonemic encephalopathy [J].
Acta Neurol Scand, 2006, 114(1): 1-7.
[2] Rath A, Naryanan TJ, Chowdhary GV, et al. Valproate-
induced hyperammonemic encephalopathy with normal
liver function [J]. Neurol India, 2005, 53(2): 226-228.
[3] Wadzinski J, Franks R, Roane D, et al. Valproate-associ-
ated hyperammonemic encephalopathy [J]. J Am Board Fam
Med, 2007, 20(5): 499-502.
[4] Deutsch SI, Burket JA, Rosse RB. Valproate-induced hy-
perammonemic encephalopathy and normal liver functions:
possible synergism with topiramate [J]. Clin Neuropharma-
col, 2009, 32(6): 350-352.
[5] Mehndiratta MM, Mehndiratta P, Phul P, et al. Valproate
induced non hepatic hyperammonaemic encephalopathy
(VNHE) l--a study from tertiary care referral university
hospital, north India [J]. J Pak Med Assoc, 2008, 58(11):
627-631.
[6] Chopra A, Kolla BP, Mansukhani MP, et al. Valproate-in-
duced hyperammonemic encephalopathy:an update on risk
factors, clinical correlates and management [J]. Gen Hosp
Psychiatry, 2012, 34(3): 290-298.
[7] 史克珊. 重视和规范继发性癫痫的治疗[J]. 中华神经外科
杂志,2006,22(5):322-323.
[8] 史玉泉. 实用神经病学[M]. 第2版. 上海:科学技术出社,
1994. 789-803.
[9] 全国神经外科癫痫防治协助组. 神经外科围手术期和外
伤后癫痫的预防及治疗指南(草案)[J]. 中华神经医学
杂志,2006,15(12):1189-1190.
[10] Carr RB, Sherws bury K. Hyperammonemia due to valproic
acid in the psychiatric setting [J]. Am J Psychiatry, 2007,
164(7): 1020-1027.
[11] Bogdanovic MD, Kidd D, Boriddon A, et al. Late onset hete-
rozygous ornithine transcarbamylase deficiency mimicking
complex partialstatusepilepticus [J]. J Neurol Neurosug
Psychiatry, 2000, 69: 813-815.
[12] Sousa C. Valproic acid-induced hyperammonemic encepha-
lopathy--a potentially fatal adverse drug reaction [J].
SpringerPlus, 2013, 2: 13.
[13] 李金恒. 临床治疗药物检测的方法和应用[M]. 第1版. 北
京:人民卫生出版社,2003. 42.
[14] 徐叔云. 中华临床药物学[M]. 北京:人民卫生出版社,
2003. 597.